BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28461360)

  • 21. Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective.
    Nugent RA; Husain MJ; Kostova D; Chaloupka F
    PLoS One; 2020; 15(2):e0228564. PubMed ID: 32027710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Private health care expenditure and quality in Beveridge systems: cross-regional differences in the Italian NHS.
    Del Vecchio M; Fenech L; Prenestini A
    Health Policy; 2015 Mar; 119(3):356-66. PubMed ID: 25467792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving the Agenda on Noncommunicable Diseases: Policy Implications of Mobile Phone Surveys in Low and Middle-Income Countries.
    Pariyo GW; Wosu AC; Gibson DG; Labrique AB; Ali J; Hyder AA
    J Med Internet Res; 2017 May; 19(5):e115. PubMed ID: 28476720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care spending growth: can we avoid fiscal Armageddon?
    Chernew M
    Inquiry; 2010-2011 Winter; 47(4):285-95. PubMed ID: 21391454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can higher spending on primary healthcare mitigate the impact of ageing and non-communicable diseases on health expenditure?
    Hou X; Liu L; Cain J
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36564087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National health accounts in developing countries: appropriate methods and recent applications.
    Berman PA
    Health Econ; 1997; 6(1):11-30. PubMed ID: 9142528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Knowledge, Attitudes, and Practices Related to Breast and Cervical Cancers in Mongolia: A National Population-Based Survey.
    Yerramilli P; Dugee O; Enkhtuya P; Knaul FM; Demaio AR
    Oncologist; 2015 Nov; 20(11):1266-73. PubMed ID: 26417038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of DNA sequencing for noncommunicable diseases in low-income and middle-income countries' primary care settings: A narrative synthesis.
    González-Robledo LM; Serván-Mori E; Casas-López A; Flores-Hernández S; Bravo ML; Sánchez-González G; Nigenda G
    Int J Health Plann Manage; 2019 Jan; 34(1):e46-e71. PubMed ID: 30408231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What should a country spend on health care?
    Savedoff WD
    Health Aff (Millwood); 2007; 26(4):962-70. PubMed ID: 17630438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bucking the trend? Health care expenditures in low-income countries 1990-1995.
    Jowett M
    Int J Health Plann Manage; 1999; 14(4):269-85. PubMed ID: 11184914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary.
    Goryakin Y; Suhrcke M
    Int J Equity Health; 2014 Nov; 13():107. PubMed ID: 25376485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Chronology of Global Assistance Funding for NCD.
    Nugent R
    Glob Heart; 2016 Dec; 11(4):371-374. PubMed ID: 27938820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Household coping strategies after an adult noncommunicable disease death in Bangladesh.
    Mirelman AJ; Trujillo AJ; Niessen LW; Ahmed S; Khan JAM; Peters DH
    Int J Health Plann Manage; 2019 Jan; 34(1):e203-e218. PubMed ID: 30187582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncommunicable disease outcomes and the effects of vertical and horizontal health aid.
    Kostova D; Nugent R; Richter P
    Econ Hum Biol; 2021 May; 41():100935. PubMed ID: 33388634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relative Effects of Economic Growth, Environmental Pollution and Non-Communicable Diseases on Health Expenditures in European Union Countries.
    Badulescu D; Simut R; Badulescu A; Badulescu AV
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financing the response to HIV in low-income and middle-income countries.
    Izazola-Licea JA; Wiegelmann J; Arán C; Guthrie T; De Lay P; Avila-Figueroa C
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S119-26. PubMed ID: 19901624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.